Note: Ingredients listed on restricted chemical lists
EC/CAS
236-675-5/13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
0.3-<2 022-006-
EC/CAS
232-674-9/9004-34-6
Name of the chemical
cellulose
Concentration
N/A
General Information
Revision date
2022-02-16
Product name
MARAVIROC FILM-COATED TABLETS
Product Synonyms
AXENTRI TABLETS * CELSENTRI TABLETS * CELSENTRI TABLETS 150MG * CELSENTRI BR *
Icons in SDS
Company Information
company name
ViiV Healthcare Limited
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H373
Hazard statements
Code
Statements
H373
May cause damage to organs through prolonged or repeated exposure
Section 2
2.1 Classification of the substance or mixture
The mixture has been assessed and/or tested for its physical, health and environmental hazards and the following classification applies.
EU Classification
Regulation (EC) No 1272/2008 as amended
Health hazards
Specific target organ toxicity - repeated Category 2 H373 - May cause damage to exposure organs through prolonged or repeated exposure. Hazard summary Caution - Pharmaceutical agent. May cause damage to organs through prolonged or repeated exposure. Dust or powder may irritate eye tissue. See section 11 of the SDS for additional information on health hazards.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended
Contains
CALCIUM PHOSPHATE, DIBASIC, MARAVIROC, MICROCRYSTALLINE CELLULOSE, Titanium dioxide
Signal word
Warning
Hazard statements
H373 May cause damage to organs through prolonged or repeated exposure.
Prevention
P260 Do not breathe dust/fume/gas/mist/vapours/spray.
Response
P314 Get medical advice/attention if you feel unwell.
Storage
Not available.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Supplemental label elements
72.6576 % of the mixture consists of component(s) of unknown acute oral toxicity. 77.8896 % of the mixture consists of component(s) of unknown acute dermal toxicity. 77.8896 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 53.8496 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
2.3 Other hazards
Assume that this material is capable of sustaining combustion. Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.